Jt Stratford LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jt Stratford LLC

$484 Million
Q1 2024

A detailed history of Jt Stratford LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jt Stratford LLC holds 1,965 shares of REGN stock, worth $2.01 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

1,965

Previous 1,489 31.97%

Holding current value

$2.01 Million

Previous $1.31 Million 44.68%

% of portfolio

0.39%

Previous 0.31%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $429,680 - $472,834	476 Added 31.97%	1,965 $1.89 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $13,953 - $15,870	18 Added 1.22%	1,489 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $264,515 - $322,549	382 Added 35.08%	1,471 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $809,934 - $960,714	-1,157 Reduced 51.51%	1,089 $782,000
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $177,607 - $215,839	261 Added 13.15%	2,246 $1.85 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $832,244 - $903,573	1,179 Added 146.28%	1,985 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $72,320 - $91,264	-126 Reduced 13.52%	806 $555,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $39,481 - $53,196	72 Added 8.37%	932 $551,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $159,492 - $187,179	-268 Reduced 23.76%	860 $601,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $252,718 - $312,001	465 Added 70.14%	1,128 $712,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $380,581 - $451,476	663 New	663 $401,000

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $110B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.

Account